Breast Capsule Thickness and Clinical Capsular Contracture: A Systematic Review and Meta-Analysis.

Aesthetic plastic surgery 2026 Vol.50(3) p. 1171-1180

Mehdizadeh M, Furnary T, Li JH, Knerr RM, Brunson A, Foppiani J, Lee D, Escobar-Domingo MJ, Hernandez Alvarez A, Lin SJ

관련 도메인

Abstract

[BACKGROUND] Capsular contracture is a leading cause of morbidity after breast augmentation and often necessitates reoperation. This study analyzes the association between breast capsule thickness and severity of capsular contracture, distinguishing benign from pathological cases.

[METHODS] Literature review was conducted across PubMed, Medline, and Web of Science according to PRISMA guidelines, for articles published between 2014 and 2024. Data extracted included author, year, sample size, age, implant type, capsule thickness, capsular contracture presence, and Baker score. A permutation test determined a minimum thickness cutoff associated with capsular contracture. Statistical meta-analysis, permutation analysis, and univariate Poisson regression were conducted using R 4.4.1 (Boston, MA).

[RESULTS] Of 649 publications, 12 met inclusion criteria, examining 590 breast samples from 403 patients. The mean capsular thickness was 708 µm. The capsular contracture rate was 47.6% of breasts and in 69.7% of patients. Meta-regression of 534 samples across nine studies including 25 unique patient groupings showed a pooled capsular contracture rate in breasts of 58.2% (95% CI: 28.2-83.1). Capsular thicknesses in the highest (OR 23.99, 95% CI: 13.31-45.10, p < 0.001) and middle (OR 16.22, 95% CI: 9.95-27.16, p < 0.001) tertiles had higher odds of contracture compared to the lowest tertile. Univariate Poisson regression showed a 0.069% (95% CI: 0.050-0.087, p < 0.001) increase in contracture per micrometer of capsule thickness. The minimum significant cutoff was 601.5 µm (p < 0.05), below which studies had significantly lower capsular contracture rates.

[CONCLUSIONS] Capsule thickness correlates with capsular contracture, suggesting a measurable predictor for pathological contracture.

[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 capsular contracture 피막구축 dict 9
해부 breast 유방 dict 4
시술 breast augmentation 유방성형술 dict 1
해부 Baker scispacy 1
해부 breasts scispacy 1
해부 capsular scispacy 1
약물 [BACKGROUND] Capsular scispacy 1
약물 [CONCLUSIONS] Capsule scispacy 1
질환 Contracture C0009917
Contracture
scispacy 1
질환 breasts C0006141
Breast
scispacy 1
질환 lower capsular contracture C1707264
Capsular Contracture
scispacy 1
질환 Breast Capsule scispacy 1
질환 capsule scispacy 1
질환 breast samples scispacy 1
기타 capsular scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Humans; Implant Capsular Contracture; Female; Breast Implants; Breast Implantation; Risk Assessment; Breast; Adult; Severity of Illness Index

📑 인용 관계

이 논문이 참조한 문헌 21

외부 PMID 1건 (DB 미수집)

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문